Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.660
+0.040 (1.53%)
At close: Aug 21, 2026, 4:00 PM EDT
2.680
+0.020 (0.75%)
After-hours: Aug 21, 2026, 6:59 PM EDT
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $11.77 million as of August 21, 2026. Its market cap has increased by 29.33% in one year.
Market Cap
11.77M
Enterprise Value
-4.74M
1-Year Change
29.33%
Ranking
Category
Stock Price
$2.66
ChartMarket Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $11.77M, a decrease of -69.75%. That is a compound annual growth rate of -9.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 11.80M | 63.89% |
| Dec 31, 2025 | 7.20M | -27.27% |
| Dec 31, 2024 | 9.90M | 147.50% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
| Feb 13, 2015 | 38.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 12.59M |
| Adial Pharmaceuticals | 12.42M |
| Instinct Bio Technical Company Holdings | 12.03M |
| IN8bio | 12.03M |
| Moleculin Biotech | 11.69M |
| Lisata Therapeutics | 11.58M |
| Aspire Biopharma Holdings | 11.56M |
| Theriva Biologics | 11.17M |